Kreatech Licenses Veridex Technology for DNA Screening | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dutch molecular diagnostics firm Kreatech Diagnostics said it has entered into an exclusive licensing agreement providing it access to Veridex's Repeat-Free technology for the production and distribution of FISH and CISH DNA screening solutions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.